From the Research
Denmark banned ashwagandha in 2022 due to safety concerns related to its high content of withaferin A, a compound that may cause liver damage and miscarriages. The Danish Veterinary and Food Administration found that ashwagandha products contained potentially harmful levels of this compound, which could pose serious health risks, particularly for pregnant women. This decision reflects growing caution about herbal supplements that haven't undergone rigorous safety testing. While ashwagandha has been used in traditional Ayurvedic medicine for centuries and is claimed to help with stress, anxiety, and inflammation, Denmark prioritized consumer safety given the potential for adverse effects. Some studies have shown the potential benefits of ashwagandha, such as a study published in 2023, which found that ashwagandha root extract alleviated stress, anxiety, and improved quality of life in healthy adults by modulating stress hormones 1. However, the potential risks associated with ashwagandha, particularly for pregnant women, outweigh its potential benefits. Other countries have not necessarily followed Denmark's approach, as regulations for herbal supplements vary internationally. It is essential to prioritize consumer safety and consider the potential risks and benefits of herbal supplements like ashwagandha. Key points to consider:
- Ashwagandha may cause liver damage and miscarriages due to its high content of withaferin A
- Denmark banned ashwagandha in 2022 due to safety concerns
- Ashwagandha has been used in traditional Ayurvedic medicine for centuries to help with stress, anxiety, and inflammation
- Regulations for herbal supplements vary internationally
- Consumer safety should be prioritized when considering the use of herbal supplements like ashwagandha.